The Oct. 2-3 hybrid workshop will bridge the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.

Amelia™-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel MetAP2 inhibitor, controlled PI3K-induced hyperglycemia in the first study patient, consistent with pre-clinical data. Further, ctDNA data shows no evidence of residual PIK3CA mutation in blood after 6 weeks of treatment.

Rapid NSCLC Biomarker Test already demonstrated its significant impact and clinical benefits as part of a lung cancer clinical study.

Making an impact to support the fight against breast cancer.

Leveraging AI-based molecular profiling from a digitized biopsy image to enable physicians to gain immediate oncology intelligence.

The ImageneOI rapid AI-based biomarker profiling platform significantly improves lung cancer patient outcomes, as demonstrated by a recently published case report.

Carebox to help LCRF advance lung cancer research by making it easier and more effective for patients, caregivers and healthcare professionals to identify relevant lung cancer trials.

A groundbreaking case report publication on the impact of rapid molecular testing on lung cancer patients

CA CURE - its FY23 campaign - was the biggest in its 60-year history and will continue in the coming year.

Card's 18-year journey begins with cancer survivor Tyler Gressle's Make-A-Wish Foundation request and concludes with next week's Beckett/eBay/Collectable auction

Pilot of EHR-embedded clinical trial matching to enhance diversity in cancer research set to begin at two hospital systems in Texas and West Virginia.

AdMeTech Foundation's 14th Annual Prostate Cancer Awareness Day Highlights Massachusetts Model of National Leadership in Public Awareness, Education, Research and Clinical Equity

All-new Yunuverse cloud community capabilities, now standard on the Yunu platform, make it possible for over 1,000 on-demand specialty-trained radiologists, technologists, and study staff to be invited and instantly participate in any of the 4,000 in-flight imaging clinical trials running on the system today. Cancer centers may now extend the reach of trial programs to satellite sites and imaging centers, improving patient access to sophisticated oncology trials.

The Glioblastoma Foundation® launched a new awareness campaign today featuring Morgan Myles as the celebrity ambassador with the goal of raising awareness of Glioblastoma — the most lethal and common form of brain cancer.

New Board Members Announced at 2023 Tandem Meetings in Orlando, FL

First-ever award will be presented at the 2023 Tandem Meetings in conjunction with the inaugural GVHD Day on Friday, Feb. 17, 2023

Whittier Street Health Center Is 1 of 22 Health Centers Nationwide to Receive a Grant to Expand Breast Cancer Screenings in Vulnerable Communities

Massive Bio announced the launch of "Donation for Life," a new awareness campaign created to support cancer associations and foundations in the United States and Europe.

Endomag reaches a major milestone in its mission to deliver the best standard of breast cancer care for women around the world, with latest FDA approval.

Founder of Man Up to Cancer Launches New Book to Address the Unique Challenges of Men with Cancer

The Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists will Gather for the 2023 Tandem Meetings to Improve the Lives of Patients with Blood-Related Disorders and Solid Tumors.

In response to a call for tenders, Tribun Health had to undergo numerous evaluations and a rating system before joining the UniHA network in digital pathology.

Annual Awards Program Recognizes Innovation in the Global Life Sciences and Biotechnology Industry

Virtual workshop on Nov. 17-18 bridges the gap between critical stakeholders to pinpoint today's challenges and create forward-thinking solutions that enable the cell and gene therapy industry to create and deliver life-saving treatments equitably.